beta-(5-hydroxy-2-pyridyl)alanine has been researched along with Diabetes Mellitus in 1 studies
*Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YJ; Cheng, YW; Fitriana, I; Hsiao, G; Hsu, TJ; Lee, CC; Li, CH; Wu, CH | 1 |
1 other study(ies) available for beta-(5-hydroxy-2-pyridyl)alanine and Diabetes Mellitus
| Article | Year |
|---|---|
Activation of aryl hydrocarbon receptor by azatyrosine-phenylbutyric hydroxamide inhibits progression of diabetic retinopathy mice.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Mice; Receptors, Aryl Hydrocarbon; Retinal Pigments; Vascular Endothelial Growth Factor A | 2023 |